Ruzzenente Benedetta, Rötig Agnès, Metodiev Metodi D
INSERM U1163, Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, 75015 Paris, France.
INSERM U1163, Université Paris Descartes-Sorbonne Paris Cité, Institut Imagine, 75015 Paris, France
Hum Mol Genet. 2016 Oct 1;25(R2):R115-R122. doi: 10.1093/hmg/ddw176. Epub 2016 Jun 21.
Mitochondrial diseases are heterogeneous and incurable conditions typically resulting from deficient ATP production in the cells. Mice, owing to their genetic and physiological similarity to humans as well as their relatively easy maintenance and propagation, are extremely valuable for studying mitochondrial diseases and are also indispensable for the preclinical evaluation of novel therapies for these devastating conditions. Here, we review the recent exciting developments in the field focusing on mouse models for mitochondrial disease genes although models for genes not involved in the pathogenesis of mitochondrial disease and therapeutic proof-of-concept studies using mouse models are also discussed.
线粒体疾病是一类异质性且无法治愈的病症,通常是由细胞内ATP生成不足所致。小鼠由于在基因和生理方面与人类相似,且相对易于饲养和繁殖,对于研究线粒体疾病极具价值,也是针对这些严重病症的新型疗法进行临床前评估时不可或缺的。在此,我们回顾该领域近期令人振奋的进展,重点关注线粒体疾病基因的小鼠模型,不过也会讨论与线粒体疾病发病机制无关的基因模型以及使用小鼠模型进行的治疗概念验证研究。